Class information for:
Level 1: POLYVINYLACETATE POVIDONE EXCIPIENT//RECEPTOR OCCUPANCY THEORY//CAS 318 98 9

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
23518 343 19.9 28%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
8 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1276458
522 3       MAGNESIUM-BULLETIN//MAGNESIUM RESEARCH//MAGNESIUM 20526
878 2             NEBIVOLOL//CARVEDILOL//BETA BLOCKERS 11463
23518 1                   POLYVINYLACETATE POVIDONE EXCIPIENT//RECEPTOR OCCUPANCY THEORY//CAS 318 98 9 343

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 POLYVINYLACETATE POVIDONE EXCIPIENT authKW 178047 1% 100% 2
2 RECEPTOR OCCUPANCY THEORY authKW 160240 1% 60% 3
3 CAS 318 98 9 authKW 118697 1% 67% 2
4 54 SHOGOIN KAWARA CHOSAKYO KU address 89024 0% 100% 1
5 ADVERSE PULMONARY EFFECT authKW 89024 0% 100% 1
6 ANTIHYPERPROLACTINEMIC ACTIVITY authKW 89024 0% 100% 1
7 BLADDER URINARY CAPACITY authKW 89024 0% 100% 1
8 CARDIOVASCULAR SELECTIVITY authKW 89024 0% 100% 1
9 CHILDHOOD AND ADOLESCENT HYPERTENSION authKW 89024 0% 100% 1
10 CHRONIC RENAL FAILURE PHARMACOKINETICS HYPERTENSION authKW 89024 0% 100% 1

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pharmacology & Pharmacy 3347 57% 0% 196
2 Medicine, General & Internal 834 24% 0% 81
3 Medicine, Research & Experimental 282 12% 0% 40
4 Cardiac & Cardiovascular System 207 11% 0% 37
5 Chemistry, Medicinal 155 7% 0% 24
6 Toxicology 22 3% 0% 11
7 Peripheral Vascular Diseases 13 3% 0% 9
8 Nursing 3 1% 0% 3
9 Primary Health Care 1 0% 0% 1
10 Chemistry, Organic 0 2% 0% 8

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 54 SHOGOIN KAWARA CHOSAKYO KU 89024 0% 100% 1
2 TOKUSHIMA ANALYT 89024 0% 100% 1
3 IND PHARM PROGRAM 9620 1% 5% 2
4 RECANATI INTERNAL MED 8901 0% 10% 1
5 MED PHARM BUNKYO KU 8091 0% 9% 1
6 CLIN EVALUAT DRUG EFFICACY 7573 1% 4% 2
7 PENTAG 6032 1% 3% 2
8 PHARMBUNKYO KU 5931 1% 3% 2
9 AREA ANAL MEDICAMENTOS 5562 0% 6% 1
10 MEDICOPHARMACEUT SCI 5157 1% 3% 2

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL 14570 8% 1% 28
2 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 7990 8% 0% 27
3 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 7241 7% 0% 24
4 BRITISH JOURNAL OF CLINICAL PRACTICE 5202 3% 1% 11
5 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 4542 4% 0% 15
6 PHARMATHERAPEUTICA 2538 1% 1% 3
7 JOURNAL OF DRUG DEVELOPMENT 2118 0% 2% 1
8 MUNCHENER MEDIZINISCHE WOCHENSCHRIFT 1963 2% 0% 6
9 CLINICAL PHARMACOLOGY & THERAPEUTICS 1515 3% 0% 10
10 EUROPEAN JOURNAL OF CARDIOLOGY 1201 0% 1% 1

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 POLYVINYLACETATE POVIDONE EXCIPIENT 178047 1% 100% 2 Search POLYVINYLACETATE+POVIDONE+EXCIPIENT Search POLYVINYLACETATE+POVIDONE+EXCIPIENT
2 RECEPTOR OCCUPANCY THEORY 160240 1% 60% 3 Search RECEPTOR+OCCUPANCY+THEORY Search RECEPTOR+OCCUPANCY+THEORY
3 CAS 318 98 9 118697 1% 67% 2 Search CAS+318+98+9 Search CAS+318+98+9
4 ADVERSE PULMONARY EFFECT 89024 0% 100% 1 Search ADVERSE+PULMONARY+EFFECT Search ADVERSE+PULMONARY+EFFECT
5 ANTIHYPERPROLACTINEMIC ACTIVITY 89024 0% 100% 1 Search ANTIHYPERPROLACTINEMIC+ACTIVITY Search ANTIHYPERPROLACTINEMIC+ACTIVITY
6 BLADDER URINARY CAPACITY 89024 0% 100% 1 Search BLADDER+URINARY+CAPACITY Search BLADDER+URINARY+CAPACITY
7 CARDIOVASCULAR SELECTIVITY 89024 0% 100% 1 Search CARDIOVASCULAR+SELECTIVITY Search CARDIOVASCULAR+SELECTIVITY
8 CHILDHOOD AND ADOLESCENT HYPERTENSION 89024 0% 100% 1 Search CHILDHOOD+AND+ADOLESCENT+HYPERTENSION Search CHILDHOOD+AND+ADOLESCENT+HYPERTENSION
9 CHRONIC RENAL FAILURE PHARMACOKINETICS HYPERTENSION 89024 0% 100% 1 Search CHRONIC+RENAL+FAILURE+PHARMACOKINETICS+HYPERTENSION Search CHRONIC+RENAL+FAILURE+PHARMACOKINETICS+HYPERTENSION
10 DOPAMINE D 2 RECEPTOR OCCUPANCY PHARMACOKINETIC PHARMACODYNAMIC MODEL 89024 0% 100% 1 Search DOPAMINE+D+2+RECEPTOR+OCCUPANCY+PHARMACOKINETIC+PHARMACODYNAMIC+MODEL Search DOPAMINE+D+2+RECEPTOR+OCCUPANCY+PHARMACOKINETIC+PHARMACODYNAMIC+MODEL

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 NACE, GS , WOOD, AJJ , (1987) PHARMACOKINETICS OF LONG-ACTING PROPRANOLOL - IMPLICATIONS FOR THERAPEUTIC USE.CLINICAL PHARMACOKINETICS. VOL. 13. ISSUE 1. P. 51-64 26 70% 25
2 FRISHMAN, WH , COVEY, S , (1990) PENBUTOLOL AND CARTEOLOL - 2 NEW BETA-ADRENERGIC BLOCKERS WITH PARTIAL AGONISM.JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 30. ISSUE 5. P. 412-421 20 53% 11
3 DVORNIK, D , KRAML, M , DUBUC, J , COELHO, J , NOVELLO, LA , ARNOLD, JD , MULLANE, JF , (1983) RELATIONSHIP BETWEEN PLASMA PROPRANOLOL CONCENTRATIONS AND DOSE OF LONG-ACTING PROPRANOLOL (INDERAL LA).CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL. VOL. 34. ISSUE 4. P. 595-605 15 88% 5
4 SCHOENBERGER, JA , (1989) USEFULNESS OF PENBUTOLOL FOR SYSTEMIC HYPERTENSION.AMERICAN JOURNAL OF CARDIOLOGY. VOL. 63. ISSUE 18. P. 1339-1342 10 77% 4
5 BOTTINI, PB , DEVANE, JG , CORRIGAN, OI , (1984) SUSTAINED ABSORPTION DOES NOT NECESSARILY REDUCE THE SYSTEMIC AVAILABILITY OF PROPRANOLOL.DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY. VOL. 10. ISSUE 10. P. 1757-1775 9 100% 4
6 MISHRIKI, AA , WEIDLER, DJ , (1983) LONG-ACTING PROPRANOLOL (INDERAL LA) - PHARMACOKINETICS, PHARMACODYNAMICS AND THERAPEUTIC USE.PHARMACOTHERAPY. VOL. 3. ISSUE 6. P. 334-341 12 80% 6
7 SCHLANZ, KD , THOMAS, RL , (1990) PENBUTOLOL - A NEW BETA-ADRENERGIC BLOCKING-AGENT.DICP-THE ANNALS OF PHARMACOTHERAPY. VOL. 24. ISSUE 4. P. 403-408 12 48% 2
8 AMEMIYA, M , TABEI, K , FURUYA, H , SAKAIRI, Y , ASANO, Y , (1992) PHARMACOKINETICS OF CARTEOLOL IN PATIENTS WITH IMPAIRED RENAL-FUNCTION.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 43. ISSUE 4. P. 417-421 5 100% 0
9 BISWAS, NR , GARG, SK , LAL, R , KUMAR, N , GYAWALI, K , NARENDRANATH, KA , SHARMA, PL , (1988) PHARMACOKINETIC STUDY OF A NEW SUSTAINED-RELEASE PREPARATION OF PROPRANOLOL IN NORMAL HEALTHY-VOLUNTEERS.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. VOL. 26. ISSUE 9. P. 436-438 5 100% 0
10 GARG, DC , JALLAD, NS , MISHRIKI, A , CHALAVARYA, G , KRAML, M , FENCIK, M , WEIDLER, DJ , (1987) COMPARATIVE PHARMACODYNAMICS AND PHARMACOKINETICS OF CONVENTIONAL AND LONG-ACTING PROPRANOLOL.JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 27. ISSUE 5. P. 390-396 6 86% 5

Classes with closest relation at Level 1


Rank Class id link
1 18811 BISOPROLOL//BISOPROLOL EFFICACY//INTRAVESICAL BCG INSTILLATION
2 11131 COLLATERAL CORONARY FLOW//BETA BLOCKERS//METOPROLOL
3 7286 ATENOLOL//4 HYDROXYPROPRANOLOL//METOPROLOL
4 20681 CELIPROLOL//PERINDOPRIL THERAPEUTIC USE//1 BETA ADRENERGIC RECEPTOR
5 12676 AMOSULALOL//DILEVALOL//AARHUS CTY HOSP MED 1
6 34200 24 H MONITORING OF BP//CHECKLIST QUESTIONNAIRES//CO RENITEC
7 18303 ANTIHYPERTENSIVE PHARMACOTHERAPY//ACE INHIBITION ECHOCARDIOGRAPHY EXERCISES HEMODYNAMICS//ASYSTEMATIC VERTIGO
8 24830 NIPRADILOL//BOPINDOLOL//BOPINDOLOL METABOLITES
9 30907 ABS SANTA COLOMA GRAMENET 6//ACID BASE EXCRETION//BETA2 ANDRENERGIC RECEPTOR GENE
10 16705 DEPRESSIVE DISORDER CHEMICALLY INDUCED//DRUG INDUCED DEPRESSION//2 DIMENSIONAL OUTCOME

Go to start page